| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRS | Common Stock | Award | $380,001 | +85,973 | +16% | $4.42 | 632,231 | 10 Jun 2021 | Direct | F1 |
| transaction | ATRS | Common Stock | Tax liability | $102,394 | -23,010 | -3.6% | $4.45 | 609,221 | 11 Jun 2021 | Direct | F2 |
| transaction | ATRS | Common Stock | Tax liability | $65,816 | -14,790 | -2.4% | $4.45 | 594,431 | 13 Jun 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRS | Stock Option (right to buy) | Award | $0 | +163,963 | $0.000000 | 163,963 | 10 Jun 2021 | Common Stock | 163,963 | $4.42 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant. |
| F2 | Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold. |
| F3 | Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan. |
| F4 | The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. |